GlassScriptPhysician profile
David D Quinlan
NPI 1326458308
$995.77
in general payments reported to CMS, 2019-2025
14 companies · $597 in 2025
The $597 reported for 2025 was more than what 76% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.01 · 2022: $64.66 · 2023: $245 · 2024: $76.52 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $311.29 | 2025 | Grafix Pl, Stravix Pl, Oasis |
| Paratek Pharmaceuticals, INC. | $245.72 | 2022-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $140.61 | 2023 | |
| Abbvie INC. | $46.33 | 2022-2024 | |
| Nevro Corp. | $36.57 | 2023 | Senza |
| Treace Medical Concepts, INC. | $34.74 | 2025 | |
| Paragon 28, INC. | $30.29 | 2025 | Mtp |
| Cashflow Solutions, LLC | $29.15 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Convatec INC. | $27.23 | 2024 | |
| Orthofix Medical, INC. | $23.80 | 2025 | Physio-Stim |
| Stryker Corporation | $21.21 | 2024 | Augment Injectable |
| Averitas Pharma INC. | $20.20 | 2023 | Qutenza |
| Bioventus LLC | $15.62 | 2025 | Exogen Ultrasound Bone Healing System |
| Nabriva Therapeutics, Plc | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Quinlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.